Respiratory Department, H. Sª Oliveira, Guimarães, Portugal; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's, PT Government Associate Laboratory, Braga/Guimarães, Portugal.
Respiratory Department, H. Sª Oliveira, Guimarães, Portugal; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
Pulmonology. 2019 Jul-Aug;25(4):200-207. doi: 10.1016/j.pulmoe.2019.02.010. Epub 2019 May 31.
To characterise the morbidity of COPD out-patients based on symptoms, acute exacerbations, FEV and comorbidities, and to explore the association between different patients' characteristics such as social, demographic, clinical history or exposure.
Stable COPD outpatients over 40 years old diagnosed according to GOLD criteria were included consecutively; the exclusion criteria were only refusal to participate and inability to understand clinical questionnaires. A survey of demographic and clinical data was conducted. Symptoms were evaluated using the CAT and mMRC questionnaires. The number of COPD acute exacerbations reported in the previous year was assessed, and spirometry performed on all participants according to ATS/ERS recommendations. Different variables were collected and then related to each other.
We studied 303 COPD outpatients, all Caucasians, 79.5% males and mostly elderly. 65.7% of participants reported having low monthly income and 87.8% a low education level. Tobacco smoking was the most common exposure identified but a substantial proportion of COPD patients were non-smokers (26%). Frequent acute exacerbations were reported by 38.0% of patients. The mean post-bronchodilator FEV was 53.2%. The distribution of patients according to GOLD 2017 stage and classification was respectively 9.9%, 41.9%, 35.0% and 13.2% from 1 to 4 and 23.1%, 39.6%, 2.3% and 35.0% from GOLD A to D. Only 29 patients (9.5%) presented no comorbid conditions, and the most common were hypertension, heart diseases and dyslipidaemia.
Our data confirms COPD as a complex and heterogeneous disorder, with a significant morbidity due to the nature of symptoms, frequent comorbidities and exacerbations. A substantial proportion of COPD patients were never-smokers, mainly women, calling attention to the need for COPD recognition in these cases. COPD in women, in never-smokers and in patients with a previous diagnosis of asthma presented some specific characteristics. Some patient characteristics are associated with frequent acute exacerbations. FEV was strongly related both to symptoms and exacerbations.
根据症状、急性加重、FEV 和合并症来描述 COPD 门诊患者的发病率,并探讨不同患者特征(如社会、人口统计学、临床病史或暴露情况)之间的关联。
连续纳入根据 GOLD 标准诊断的 40 岁以上稳定 COPD 门诊患者;排除标准仅为拒绝参与和无法理解临床问卷。进行了人口统计学和临床数据调查。使用 CAT 和 mMRC 问卷评估症状。评估了前一年报告的 COPD 急性加重次数,并根据 ATS/ERS 建议对所有参与者进行了肺功能检查。收集了不同的变量并进行了相互关联。
我们研究了 303 名 COPD 门诊患者,均为白种人,79.5%为男性,年龄较大。65.7%的患者报告收入低,87.8%的患者受教育程度低。吸烟是最常见的暴露因素,但相当一部分 COPD 患者不吸烟(26%)。38.0%的患者报告频繁发生急性加重。根据 2017 年 GOLD 分期和分类,平均支气管扩张剂后 FEV 的分布分别为 1 至 4 期的 9.9%、41.9%、35.0%和 13.2%,GOLD A 至 D 的 23.1%、39.6%、2.3%和 35.0%。仅有 29 名患者(9.5%)无合并症,最常见的合并症是高血压、心脏病和血脂异常。
我们的数据证实 COPD 是一种复杂且异质性的疾病,由于症状、频繁合并症和急性加重的性质,发病率较高。相当一部分 COPD 患者从不吸烟,主要是女性,这表明需要在这些情况下识别 COPD。女性、从不吸烟和既往哮喘诊断的 COPD 患者具有一些特定特征。一些患者特征与频繁的急性加重有关。FEV 与症状和急性加重均密切相关。